Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human umbilical cord blood serum with microneedling versus serum injection alone for facial skin rejuvenation and hyperpigmentation
IRCT20221130056672N9Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human umbilical cord blood serum in Hyperpigmentation and photoaging (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Skin elasticity, Collagen levels and 3 more. Started Jun 2025; status: completed.
02
Drugs
human umbilical cord blood serum
03
Conditions
Hyperpigmentationphotoaging
Beyond the preview
Go deeper on IRCT20221130056672N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221130056672N9.